ATE456054T1 - PROTEIN FRUITS SUPPLEMENTATION TESTS - Google Patents

PROTEIN FRUITS SUPPLEMENTATION TESTS

Info

Publication number
ATE456054T1
ATE456054T1 AT99936199T AT99936199T ATE456054T1 AT E456054 T1 ATE456054 T1 AT E456054T1 AT 99936199 T AT99936199 T AT 99936199T AT 99936199 T AT99936199 T AT 99936199T AT E456054 T1 ATE456054 T1 AT E456054T1
Authority
AT
Austria
Prior art keywords
protein
dhfr
fragment
fragments
interactions
Prior art date
Application number
AT99936199T
Other languages
German (de)
Inventor
Stephen Michnick
Joelle Pelletier
Ingrid Remy
Original Assignee
Odyssey Thera Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/124,850 external-priority patent/US6294330B1/en
Application filed by Odyssey Thera Inc filed Critical Odyssey Thera Inc
Priority claimed from PCT/CA1999/000702 external-priority patent/WO2000007038A2/en
Application granted granted Critical
Publication of ATE456054T1 publication Critical patent/ATE456054T1/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1055—Protein x Protein interaction, e.g. two hybrid selection
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/581—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with enzyme label (including co-enzymes, co-factors, enzyme inhibitors or substrates)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)

Abstract

We describe a strategy for designing and implementing protein-fragment complementation assays (PCAs) to detect biomolecular interactions in vivo and in vitro. A Protein Complementation Assay/Universal Reporter System (PCA/URS) for detecting and screening for agonists and antagonists of a membrane receptor is also described. The design, implementation and broad applications of this strategy are illustrated with a large number of enzymes with particular detail provided for the example of murine dihydrofolate reductase (DHFR). Fusion peptides consisting of N- and Cterminal fragments of murine DHFR fused to GCN4 leucine zipper sequences were coexpressed in Escherichia coli grown in minimal medium, where the endogenous DHFR activity was inhibited with trimethoprim. Coexpression of the complementary fusion products restored colony formation. Survival only occurred when both DHFR fragments were present and contained leucine-zipper forming sequences, demonstrating that reconstitution of enzyme activity requires assistance of leucine zipper formation. DHFR fragment-interface point mutants of increasing severity (Ile to Val, Ala and Gly) resulted in a sequential increase in E. coli doubling times illustrating the successful DHFR fragment reassembly rather than non-specific interactions between fragments. This assay could be used to study equilibrium and kinetic aspects of molecular interactions including protein-protein, protein-DNA, protein-RNA, protein-carbohydrate and protein-small molecule interactions, for screening cDNA libraries for binding of a target protein with unknown proteins or libraries of small organic molecules for biological activity. The selection and design criteria applied here is developed for numerous examples of clonal selection, colorometric, fluorometric and other assays based on enzymes whose products can be measured. The development of such assay systems is shown to be simple, and provides for a diverse set of protein fragment complementation applications.
AT99936199T 1998-07-30 1999-07-30 PROTEIN FRUITS SUPPLEMENTATION TESTS ATE456054T1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CA002244349A CA2244349A1 (en) 1998-07-30 1998-07-30 Protein fragment complementation assays for the detection of biological or drug interactions
US09/124,850 US6294330B1 (en) 1997-01-31 1998-07-30 Protein fragment complementation assays for the detection of biological or drug interactions
PCT/CA1999/000702 WO2000007038A2 (en) 1998-07-30 1999-07-30 Protein fragment complementation assays

Publications (1)

Publication Number Publication Date
ATE456054T1 true ATE456054T1 (en) 2010-02-15

Family

ID=29409708

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99936199T ATE456054T1 (en) 1998-07-30 1999-07-30 PROTEIN FRUITS SUPPLEMENTATION TESTS

Country Status (5)

Country Link
AT (1) ATE456054T1 (en)
CA (1) CA2244349A1 (en)
DE (1) DE69941946D1 (en)
DK (1) DK1027608T3 (en)
ES (1) ES2339411T3 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7488583B2 (en) * 2003-09-25 2009-02-10 Odyssey Thera, Inc. Fragment complementation assays for G-protein-coupled receptors and their signaling pathways
CN114190538B (en) * 2021-12-21 2023-11-24 郑州轻工业大学 Grease crystallization promoter for promoting formation of beta' crystal form and application

Also Published As

Publication number Publication date
CA2244349A1 (en) 2000-01-30
ES2339411T3 (en) 2010-05-19
DK1027608T3 (en) 2010-05-25
DE69941946D1 (en) 2010-03-11

Similar Documents

Publication Publication Date Title
DK0966685T3 (en) Protein-fragment complementation assays to detect biomolecular interactions
AU2001278613B2 (en) Functional protein arrays
Lamla et al. The Nano-tag, a streptavidin-binding peptide for the purification and detection of recombinant proteins
Ohmuro-Matsuyama et al. Homogeneous noncompetitive luminescent immunodetection of small molecules by ternary protein fragment complementation
He et al. Myosin VI contains a compact structural motif that binds to ubiquitin chains
US20030198971A1 (en) Reactivation-based molecular interaction sensors
Aggarwal et al. Single‐molecule pull‐down (SiMPull) for new‐age biochemistry: Methodology and biochemical applications of single‐molecule pull‐down (SiMPull) for probing biomolecular interactions in crude cell extracts
US8426153B2 (en) Linked peptides fluorogenic biosensors
US20160054331A1 (en) Method for the detection and/or enrichment of analyte proteins and/or analyte peptides from a complex protein mixture
EP1474504A2 (en) Use of collections of binding sites for sample profiling and other applications
Stein et al. Ultrasensitive scaffold-dependent protease sensors with large dynamic range
WO2000007038A3 (en) Protein fragment complementation assays
Kast et al. 3D structural information as a guide to protein engineering using genetic selection
TWI795365B (en) Methods of making and using soluble mhc molecules
Pelletier et al. Mapping protein–protein interactions with combinatorial biology methods
Suwwan de Felipe et al. Correlation between Ligand− Receptor Affinity and the Transcription Readout in a Yeast Three-Hybrid System
CA2427747A1 (en) Affinity maturation by competitive selection
ATE456054T1 (en) PROTEIN FRUITS SUPPLEMENTATION TESTS
Groll et al. Towards multiplexed protein–protein interaction analysis using protein tag-specific nanobodies
Ha et al. Construction of allosteric protein switches by alternate frame folding and intermolecular fragment exchange
JP6624755B2 (en) Protein tag, tagged protein and protein purification method
JP6502854B2 (en) Method of identifying polyubiquitinated substrate
Genereux Mass spectrometric approaches for profiling protein folding and stability
Kim et al. On-chip Escherichia coli culture, purification, and detection of expressed proteins
Banerjee et al. Configurational entropy-based screening and selection of hydrophilic polymers using the tripartite split green fluorescent protein

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1027608

Country of ref document: EP

REN Ceased due to non-payment of the annual fee